Irazu Oncology
About:
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Website: http://www.irazuoncology.com
Description:
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Total Funding Amount:
$2.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2022-01-01
Contact Email:
bcawthern(AT)irazuoncology.com
Founders:
Marco A. Chacón
Number of Employees:
1-10
Last Funding Date:
2023-12-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai